Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds Jun 3, 2026 08:30AM
Liminatus Pharma prices $4 million public offering at $0.29 per share Feb 17, 2026 08:44AM
Liminatus Pharma prices $4 million public offering at $0.29 per share Feb 17, 2026 08:44AM
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering Feb 17, 2026 08:44AM
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering Feb 17, 2026 08:44AM